Caren van Roekel

76 Chapter 2 55. Yu N, Srinivas SM, Difilippo FP, Shrikanthan S, Levitin A, McLennan G, et al. Lung dose calculation with SPECT/ CT for (9)(0)Yittrium radioembolization of liver cancer. Int J Rad Oncol Biol Phys. 2013;85(3):834-9. Epub 2012/08/09. 56. Kao YH, Magsombol BM, Toh Y, Tay KH, Chow PKH, Goh ASW, et al. Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization. EJNMMI research. 2014;4(33). 57. Gaba RC, Zivin SP, Dikopf MS, Parvinian A, Casadaban LC, Lu Y, et al. Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting. Radiology. 2014;271(2):602-12. 58. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12(12):1711-20. 59. SalemR, Thurston KG. Radioembolization with 90Yttrium microspheres: a state- of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol. 2006;17(8):1251-78. Epub 2006/08/23. 60. SalemR, Thurston KG. Radioembolization with 90yttrium microspheres: a state- of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol. 2006;17(9):1425-39. Epub 2006/09/23. 61. SalemR, Thurston KG. Radioembolization with yttrium-90 microspheres: a state- of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. J Vasc Interv Radiol. 2006;17(10):1571-93. Epub 2006/10/24. 62. Smits MLJ, Nijsen JFW, van den Bosch MAAJ, Lam MGEH, Vente MAD, Mali WPTM, et al. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study. Lancet Oncol. 2012;13(10):1025-34. 63. Chiesa C, Mira M, Maccauro M, Spreafico C, Romito R, Morosi C, et al. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Eur J Nucl Med Mol Im. 2015;42(11):1718-38. Epub 2015/06/27. 64. Pacilio M, Ferrari M, Chiesa C, Lorenzon L, Mira M, Botta F, et al. Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodolog y. Medical physics. 2016;43(7).